A Sermorelin COA (Certificate of Analysis) provides quantitative proof of peptide purity, identity, and safety profile for preclinical research. PX1 Research supplies lot-specific third-party verification—including RP-HPLC chromatograms, mass spectrometry reports, and endotoxin analysis—for every batch of Sermorelin 2mg manufactured in our US-based GMP-compliant facilities.
A Sermorelin COA (Certificate of Analysis) provides quantitative proof of peptide purity, identity, and safety profile for preclinical research. PX1 Research supplies lot-specific third-party verification—including RP-HPLC chromatograms, mass spectrometry reports, and endotoxin analysis—for every batch of Sermorelin 2mg manufactured in our US-based GMP-compliant facilities.
In peptide synthesis and analytical biochemistry, obtaining a lot-specific Sermorelin COA is essential for validating compound integrity before commencing in vitro assays or animal models. Sermorelin is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment of endogenous Growth Hormone-Releasing Hormone—designated as GHRH(1-29)NH2. Because sequence fidelity directly dictates receptor binding kinetics, analytical documentation must confirm both sequence identity and absolute purity.
A rigorous Sermorelin COA documents two primary spectroscopic evaluations: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight verification. At PX1 Research, every production batch is analyzed by independent ISO 17025 accredited laboratories to ensure researchers receive fully characterized materials free from synthesis artifacts, truncated chains, or residual organic solvents.
When procuring reagents for laboratory study, analyzing the analytical report ensures reproducibility. Investigators evaluating pituitary somatotroph signaling or growth hormone axis dynamics require peptides with documented purity exceeding 99.0%, accompanied by verifiable mass spectrum peaks matching the theoretical mass of 3357.93 Da.
Sermorelin represents the shortest fully functional fragment of human GHRH capable of binding to and activating the GHRH receptor (GHRHR). The sequence consists of 29 amino acids: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. The C-terminal amidation enhances stability against carboxypeptidase degradation compared to free-acid forms.
In cell culture models and preclinical rodent studies, Sermorelin functions as a selective reference agonist at the GHRH receptor, a Class B G-protein-coupled receptor located on pituitary somatotrophs. Ligand binding triggers Gs-protein coupling, stimulating adenylate cyclase and inducing an intracellular elevation of cyclic adenosine monophosphate (cAMP). This signaling cascade downstream promotes protein kinase A (PKA) activation and intracellular calcium influx, ultimately driving transcriptional expression and pulsatile release of endogenous growth hormone.
Because it acts upstream of endogenous feedback loops, Sermorelin preserves native physiological regulatory mechanisms in preclinical models. To explore broader comparative mechanisms across pituitary pathways, researchers can reference our detailed guide on growth hormone secretagogues and related secretagogue families.
Evaluating a third-party Certificate of Analysis requires understanding the specific analytical metrics reported. PX1 Research provides transparent, lot-traceable COA documentation featuring the following primary specifications:
1. Purity by RP-HPLC: Quantitative peak area integration demonstrating that the target peak accounts for ≥99.0% of the total peptide area. This ensures minimal concentration of deletion sequences or deamidated byproducts. 2. Molecular Weight Verification (MS): Electrospray Ionization Mass Spectrometry confirming an experimental monoisotopic or average mass within ±1.0 Da of the theoretical target (3357.93 g/mol). 3. Endotoxin Quantitation: Chromogenic Limulus Amebocyte Lysate (LAL) testing guaranteeing bacterial endotoxin levels are strictly controlled (<0.01 EU/µg), vital for sensitive cell viability and receptor-binding assays. 4. Appearance and Solubilization: Visual confirmation of a white, lyophilized cake or powder and rapid reconstituted clarity in sterile laboratory diluents.
Sourcing Sermorelin with COA guarantees that baseline experimental variables are controlled, eliminating confounding data resulting from batch-to-batch impurities or degradation.
When designing comparative secretagogue studies, researchers often evaluate Sermorelin alongside other modified GHRH derivatives and synthetic secretagogues. Understanding structural alterations helps clarify differences in receptor affinity, enzymatic half-life, and bioactivity profiles across different test systems.
Sermorelin represents the unmodified native sequence GHRH(1-29), characterized by a relatively short biological half-life in physiological matrices due to rapid enzymatic cleavage by dipeptidyl peptidase-4 (DPP-4) between Ala2 and Asp3. In contrast, CJC-1295 without DAC incorporates D-Ala2, Gln8, Ala15, and Leu27 substitutions to enhance enzymatic resistance while maintaining GHRHR activation. Similarly, Tesamorelin features a trans-3-hexenoic acid group attached to the N-terminal tyrosine residue, granting superior stability against plasma degradation in metabolic models.
Additionally, investigators measuring synergistic GHRH and ghrelin receptor co-activation frequently combine GHRH agonists with growth hormone secretagogue receptor (GHSR-1a) agonists like Ipamorelin or GHRP-6. For a complete listing of available reference compounds, explore our comprehensive peptide catalog.
A critical feature of any reliable sermorelin coa is the attached raw chromatographic and spectral output. Researchers analyzing these reports should look for key analytical signatures:
In RP-HPLC analysis, a single sharp, symmetrical absorption peak eluted under a C18 gradient indicates high chemical purity. Minor shoulder peaks or split peaks typically signify enantiomeric impurities, incomplete deprotection during solid-phase peptide synthesis (SPPS), or oxidation at the Met27 residue. PX1 Research sets strict threshold limits ensuring total impurities do not exceed 1.0%.
In ESI-MS spectra, the primary observed signals correspond to multi-charged ion species ([M+2H]2+, [M+3H]3+, [M+4H]4+). Deconvolution of these charge states yields the precise molecular mass of the parent peptide. Discrepancies between expected and calculated mass values indicate potential sequence mutations or amino acid deletions during synthesis. Full spectral documentation can be accessed in our research library.
Bacterial endotoxins—primarily lipopolysaccharides (LPS) derived from Gram-negative outer cell membranes—pose a severe threat to in vitro cell cultures and animal models. Exposure to endotoxin-contaminated peptides induces unspecific inflammatory responses, toll-like receptor 4 (TLR4) activation, and cytokine release, masking true pharmacological signaling via GHRHR.
PX1 Research enforces strict quality thresholds on every lot of Sermorelin 2mg. Utilizing chromogenic LAL assays, each lot must pass testing with measured endotoxin content well below standard research limits (<0.01 EU/µg). This level of stringent quality assurance guarantees that observed cellular responses are attributable solely to GHRH receptor signaling rather than immunological artifacts.
Laboratories conducting multi-plate comparative screens or sensitive primary cell cultures can set up a dedicated wholesale laboratory account to reserve consistent, bulk-tested single-lot batches for long-term study protocols.
To preserve peptide structure upon receipt, proper reconstitution techniques must be observed under sterile laboratory conditions. Sermorelin 2mg is supplied as a lyophilized powder requiring reconstitution prior to liquid phase assays.
For standard cell culture or enzymatic assays, Bacteriostatic Water (0.9% benzyl alcohol) or sterile unpreserved Water for Injection (WFI) is recommended. When preparing stock solutions for physiological pH buffers (such as PBS at pH 7.4), researchers should note that Sermorelin is most stable in slightly acidic to neutral environments (pH 5.0–6.5). Avoid rapid vortexing or vigorous agitation, as shear forces can induce peptide aggregation and surface denaturation.
A standard protocol involves gently directing the solvent down the inner glass wall of the vial, allowing the solvent to passively saturate the lyophilized cake, followed by gentle swirl motion until full dissolution is observed. For detailed technical protocols regarding peptide handling, review our centralized GHRH receptor agonists resource.
Lyophilized Sermorelin displays excellent long-term stability when stored under appropriate thermal conditions. Unreconstituted vials should be kept at -20°C to -80°C in a desiccated environment to prevent atmospheric moisture absorption.
Primary chemical degradation pathways for GHRH(1-29) include oxidation of the methionine residue at position 27 (forming Met-sulfoxide), deamidation of asparagine at position 8, and hydrolytic cleavage of peptide bonds under elevated temperatures or alkaline conditions. Once reconstituted, stock solutions stored at 2°C to 8°C should be utilized within 14–28 days depending on the diluent type. For extended storage of liquid stock solutions, aliquot into single-use polypropylene tubes and freeze at -80°C to avoid repeated freeze-thaw cycles.
Navigating peptide procurement requires a vendor committed to rigorous quality control, lot traceability, and domestic production integrity. Overseas chemical sourcing frequently suffers from broad lot variability, missing analytical reports, or compromised chain-of-custody protocols.
PX1 Research synthesizes all compounds in state-of-the-art, GMP-compliant facilities located within the United States. Every lot undergoes independent, third-party validation before batch release. Furthermore, order fulfillment originates from dual logistics hubs located in California and Arizona, providing reliable same-day dispatch (Monday through Friday) for laboratory orders placed prior to cut-off times.
Whether acquiring single analytical samples of Sermorelin 2mg or establishing large-scale institutional orders, PX1 Research provides the verified chemical foundations necessary for publishable research.
Where can I find a verified sermorelin coa?
A lot-specific Sermorelin COA is accessible directly on the PX1 Research product page for Sermorelin 2mg. Each certificate includes third-party RP-HPLC chromatograms, mass spectrometry data, and verified endotoxin test results.
What guarantees come with ordering sermorelin with coa from PX1 Research?
Ordering Sermorelin with a COA ensures that your sample has undergone third-party testing confirming ≥99.0% purity by RP-HPLC, verified mass identity via ESI-MS, and endotoxin levels controlled under 0.01 EU/µg. Every batch is synthesized in US-based GMP-compliant facilities.
What is the molecular weight reported on a Sermorelin Certificate of Analysis?
The theoretical molecular weight of Sermorelin (GHRH 1-29 amide) is 3357.93 g/mol. A third-party COA will report an experimental mass matching this target value within a ±1.0 Da tolerance band via ESI-MS analysis.
How is Sermorelin purity verified via HPLC?
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) separates the primary peptide sequence from synthesis impurities or degradation products based on hydrophobicity. Purity is calculated by integrating the area under the main elution peak relative to total peak area.
Why is endotoxin testing critical for Sermorelin research compounds?
Bacterial endotoxins can stimulate unwanted inflammatory and immune responses in cell cultures or animal tissues, skewing baseline research data. Low endotoxin levels (<0.01 EU/µg) ensure observed effects are directly related to GHRH receptor interaction.
How should lyophilized Sermorelin 2mg be stored upon arrival?
Lyophilized Sermorelin should be stored at -20°C or lower in a dry, dark environment. Protected from moisture and heat, the dry powder remains stable for up to 24 months.
What is the recommended reconstitution solvent for laboratory Sermorelin assays?
Sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile unpreserved Water for Injection (WFI) is typically used for liquid stock preparation. Avoid strong alkaline buffers to prevent peptide hydrolytic degradation.
How long is reconstituted Sermorelin stable at 4°C?
Reconstituted liquid stock solutions prepared with bacteriostatic water remain stable at 2°C to 8°C for up to 28 days. Solutions in unpreserved sterile water should be used immediately or stored frozen in single-use aliquots at -80°C.
How does Sermorelin compare to CJC-1295 in structural stability?
Sermorelin is the native GHRH(1-29) sequence and is subject to rapid cleavage by DPP-4 enzymes. CJC-1295 contains structural substitutions (such as D-Ala2) designed to resist enzymatic breakdown and prolong plasma half-life in preclinical models.
Can institution research labs establish bulk orders for Sermorelin?
Yes, academic and industrial laboratories can set up a wholesale account with PX1 Research to secure single-lot batch allocations, customized vial sizes, and institutional pricing structures.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.